Aller au contenu

Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment-free remission period after imatinib discontinuation: Results of the French Nilo post-STIM study.

Nom du journal : Br J Haematol

Année : 2023

Volume : 201

Page de départ : 1116-1124

Auteurs: Dulucq, S, Rigal-Huguet, F, Nicolini, FE, Cony-Makhoul, P, Escoffre-Barbe, M, Gardembas, M & al,